To be held virtually on Thursday, November 18th, 9:00 am – 11:30 am
Dr. Ezekiel Emanuel, MD
Vice Provost for Global Initiatives, Diane v.S. Levy and Robert M. Levy University Professor, and Co-Director of the Healthcare Transformation Institute University of Pennsylvania
Dr. Ezekiel Emanuel, MD, is one of the leading practitioners shaping the future of health care, with a long record of experience at the top levels of policy. Trained both as an oncologist (MD, Harvard Medical School) and a political scientist, Zeke offers a uniquely thoughtful perspective on the most difficult issues in medicine today. From 2009 to 2011, Zeke was a special advisor for health policy to the White House Office of Management and Budget. As one of the most prominent voices advising the White House about health care, he had a significant impact on federal health care budgets and the Affordable Care Act. Dr. Emanuel is the Vice Provost for Global Initiatives, and the Diane v.S. Levy and Robert M. Levy University Professor at the University of Pennsylvania. He is a founding chair at the Clinical Center of the National Institutes of Health. Dr. Emanuel is also a Special Advisor to the Director General of the World Health Organization (WHO). He is the author of 15 books including, Reinventing American Health Care and Prescription for the Future. Dr. Emanuel published two new books in 2020. The first, co-authored with Abbe Gluck, evaluates the Affordable Care Act ten years after the landmark legislation and is titled The Trillion Dollar Experiment (March 2020), and the other is Which Country Has the Best Health Care in the World? (June 2020), an examination of ten health care systems across the globe, in search of the best. Dr. Emanuel will share his perspective on the Biden Administration’s impact on health care policy in Massachusetts and throughout the U.S. Please click here for full bio.
Full agenda to follow
Thank you to our generous sponsors…
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases.
Reliable Respiratory is one of the leading independently owned home respiratory and specialty medical equipment providers in the U.S., providing equipment and service to patients throughout New England.